Fidelity National Information Services (NYSE:FIS – Get Rating) had its price objective increased by stock analysts at Mizuho from $78.00 to $80.00 in a research note issued on Monday, The Fly reports. Mizuho’s price target would suggest a potential upside of 36.24% from the company’s previous close. A number of other research firms have also […]
S&CO Inc. bought a new stake in shares of Amgen Inc. (NASDAQ:AMGN – Get Rating) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 834 shares of the medical research company’s stock, valued at approximately $219,000. Other hedge funds have also modified their […]
Brinker Capital Investments LLC lessened its stake in Amgen Inc. (NASDAQ:AMGN – Get Rating) by 8.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 22,014 shares of the medical research company’s stock after selling 2,056 shares during the quarter. Brinker Capital Investments LLC’s holdings […]
Westpac Banking Corp grew its position in Amgen Inc. (NASDAQ:AMGN – Get Rating) by 0.3% during the 4th quarter, Holdings Channel.com reports. The firm owned 102,819 shares of the medical research company’s stock after purchasing an additional 285 shares during the period. Westpac Banking Corp’s holdings in Amgen were worth $27,004,000 as of its most […]
Arjuna Capital raised its stake in shares of Amgen Inc. (NASDAQ:AMGN – Get Rating) by 3.5% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 21,421 shares of the medical research company’s stock after buying an additional 721 shares during the period. Amgen comprises […]